These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25232238)

  • 1. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    World J Gastroenterol; 2014 Sep; 20(34):12018-25. PubMed ID: 25232238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of infection control in prevention of hepatitis B virus (HBV) in hemodialysis (HD) patients.
    Yassin MH; Gupta V
    Infect Disord Drug Targets; 2013 Jun; 13(3):162-8. PubMed ID: 23961738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations.
    Elamin S; Abu-Aisha H
    Arab J Nephrol Transplant; 2011 Jan; 4(1):35-47. PubMed ID: 21469594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination in dialysis centres: advantages and limits.
    Rapicetta M
    Nephron; 1992; 61(3):284-6. PubMed ID: 1386901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV infection in hemodialysis patients: monitoring and prevention.
    Carletti P; Bibiano L; Boggi R; Bordoni E; Ricciatti AM; Della Bella S; Pauri P; Salvoni G; Mioli VA
    Nephron; 1992; 61(3):269-70. PubMed ID: 1386899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study.
    Keyvani H; Agah S; Kabir A; Alavian SM
    Ann Hepatol; 2013; 12(2):213-9. PubMed ID: 23396732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status of immunity against the hepatitis B virus among vaccinated hemodialysis patients: a single center report from Iran.
    Khamene ZR; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):547-50. PubMed ID: 17951941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional serosurvey on hepatitis B vaccination uptake among adult patients from GP practices in a region of South-West Poland.
    Ganczak M; Dmytrzyk-Daniłów G; Korzeń M; Szych Z
    BMC Public Health; 2015 Oct; 15():1060. PubMed ID: 26475167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
    Kayataş M
    Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission.
    Rinonce HT; Yano Y; Utsumi T; Heriyanto DS; Anggorowati N; Widasari DI; Lusida MI; Soetjipto ; Prasanto H; Hotta H; Hayashi Y
    J Med Virol; 2013 Aug; 85(8):1348-61. PubMed ID: 23919229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: Hepatitis B and dialysis.
    Edey M; Barraclough K; Johnson DW
    Nephrology (Carlton); 2010 Mar; 15(2):137-45. PubMed ID: 20470270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult hepatitis B in patients on hemodialysis: a review.
    Fontenele AM; Filho NS; Ferreira AS
    Ann Hepatol; 2013; 12(4):527-31. PubMed ID: 23813129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular biology and serologic analysis in an epidemic of viral hepatitis B in vaccinated patients on hemodialysis].
    Nĕmecek V; Reinis M; Konopácová A; Summerová M; König J; Kubánek J
    Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):160-6. PubMed ID: 10658344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
    Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
    Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and prevention of hepatitis B virus infection.
    Kwon SY; Lee CH
    Korean J Hepatol; 2011 Jun; 17(2):87-95. PubMed ID: 21757978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus.
    Yuan J; Yang Y; Han F; Zhang P; Du XY; Jiang H; Chen JH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):302-6. PubMed ID: 22672825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.
    Cassidy A; Mossman S; Olivieri A; De Ridder M; Leroux-Roels G
    Expert Rev Vaccines; 2011 Dec; 10(12):1709-15. PubMed ID: 22085174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.